- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Omalizumab (rch) – November 2009
Omalizumab (rch), powder for injection, 150 mg, Xolair®, November 2009
Last updated
19 March 2010